Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,660.00    2.00 (0.12%)
Bid:
1,664.00
Ask:
1,666.00
Spread: 2.00 (0.12%)
Market Cap: £488.90m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

Filter Contract Award

20 Dec 2011 09:45

RNS Number : 3098U
Avon Rubber PLC
20 December 2011
 



20 December 2011

FILTER CONTRACT AWARD

Avon is pleased to announce that it has received a 5 year contract from the Department of Defense (DoD) for the supply of spare filters for its M50 respirator. Like previous contracts for spare filters, the contract is an Indefinite Delivery Indefinite Quantity ("IDIQ") contract and has a maximum order quantity of 2.4m filter pairs per year and 12m filter pairs over the contract term. The contract also allows the DoD to extend the term by 2 further option years, potentially extending the duration to 7 years. An initial order has been placed by the DoD with a value of $2.5m for immediate delivery.

This new contract is in addition to the existing sole source $38m, 3 year IDIQ contract announced in August. Avon has also received a further delivery order against this contact with a value of $6.1m for delivery by 1 April 2012.

As expected, the DoD has chosen to dual source the procurement of spare filters and another source has also been selected for a 5 year contract award. The Directors believe that it will take up to 2 years for a comparable product to be developed and approved, after which orders for filters for the M50 mask will be competitively bid. The supply of filters with M50 mask systems will remain sole sourced to Avon.

Commenting on the news, Peter Slabbert, Chief Executive said: "We are delighted to have been awarded this new contract which confirms Avon's position as a supplier of consumable filters to the DoD for a further 5 to 7 years. The procurement of the filter for the M50 mask from another supplier was expected and we believe that our state of the art manufacturing capability, our existing technology advantage and the continuation of the sole source window for up to another 2 years will allow Avon to retain its competitive advantage. We are also committed to widening our capability and product range in the area of filtration to enable us to continue to grow this repeat revenue stream."

For further enquiries, please contact:

Avon Rubber p.l.c.

Peter Slabbert, Chief Executive

01225 896 870

Andrew Lewis, Group Finance Director

01225 896 830

Fiona Stewart, Corporate Communications Executive

01225 896 871

Weber Shandwick Financial

Nick Oborne

020 7067 0700

Stephanie Badjonat

020 7067 0700

 

NOTES TO EDITORS: Avon Rubber p.l.c. is a world leader in the design, test and manufacture of advanced Chemical, Biological, Radiological and Nuclear (CBRN) respiratory protection solutions to the worlds military, law enforcement, first responder, emergency services, fire and industrial markets. Avon has a unique capability in CBRN protection based on a range of advanced CBRN technologies in respirator design, filtration and compressed air breathing apparatus. This enables Avon to develop specialised solutions that take full account of user requirements. Avon also owns a world leading dairy business manufacturing liners and tubing for the automated milking process. For further information please visit the Group's website www.avon-rubber.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTGCBDDRDDBGBG
Date   Source Headline
30th Nov 20162:11 pmRNSReplacement - Director/PDMR Shareholding
28th Nov 20164:24 pmRNSDirector/PDMR Shareholding
28th Nov 20164:19 pmRNSHolding(s) in Company
28th Nov 20162:04 pmRNSDirector/PDMR Shareholding
22nd Nov 20163:16 pmRNSHolding(s) in Company
17th Nov 20165:06 pmRNSDirector/PDMR Shareholding
16th Nov 20167:00 amRNSFinal Results
10th Nov 20161:13 pmRNSHolding(s) in Company
8th Nov 201610:39 amRNSDirector/PDMR Shareholding
18th Oct 20167:00 amRNSBoard Change and Year-End Trading Update
7th Oct 20163:34 pmRNSADOPTION OF FINANCIAL REPORTING STANDARD (FRS) 101
6th Oct 20163:55 pmRNSHolding(s) in Company
6th Oct 201612:35 pmRNSDirector/PDMR Shareholding
26th Sep 20164:24 pmRNSHolding(s) in Company
19th Sep 20164:27 pmRNSDirector/PDMR Shareholding
14th Sep 20164:31 pmRNSHolding(s) in Company
9th Sep 20167:00 amRNSTrading Update
5th Sep 20164:35 pmRNSDirector/PDMR Shareholding
5th Sep 20161:30 pmRNSDirector/PDMR Shareholding
8th Aug 201611:51 amRNSDirector/PDMR Shareholding
8th Jul 20165:35 pmRNSHolding(s) in Company
7th Jul 20165:08 pmRNSHolding(s) in Company
6th Jul 20165:44 pmRNSHolding(s) in Company
5th Jul 20164:47 pmRNSDirector/PDMR Shareholding
1st Jul 20164:24 pmRNSHolding(s) in Company
29th Jun 201611:57 amRNSDirector/PDMR Shareholding
7th Jun 20165:18 pmRNSDirector/PDMR Shareholding
7th Jun 20168:38 amRNSDirector/PDMR Shareholding
6th May 20169:49 amRNSDirector/PDMR Shareholding
6th May 20169:12 amRNSHolding(s) in Company
4th May 20164:00 pmRNSPublication of Interim Report
4th May 20167:00 amRNSHalf-year Report
7th Apr 201611:20 amRNSDirector/PDMR Shareholding
31st Mar 20169:19 amRNSHolding(s) in Company
8th Mar 20164:49 pmRNSDirector/PDMR Shareholding
8th Mar 201611:20 amRNSDirector/PDMR Shareholding
3rd Mar 20167:00 amRNSUS DOD Order
26th Feb 20164:08 pmRNSDisclosure of Home Member State
26th Feb 20162:15 pmRNSAppointment of Non-Executive Director
5th Feb 20161:17 pmRNSDirector/PDMR Shareholding
2nd Feb 201612:25 pmRNSDirector/PDMR Shareholding
1st Feb 20165:01 pmRNSDirector/PDMR Shareholding
27th Jan 201610:11 amRNSAGM Result and Director Retirement - Replacement
26th Jan 20162:08 pmRNSResult of AGM and Retirement of Director
26th Jan 20167:00 amRNSAGM Trading Update
21st Jan 20165:19 pmRNSHolding(s) in Company
21st Jan 20164:29 pmRNSDirector/PDMR Shareholding
5th Jan 20163:10 pmRNSDirector/PDMR Shareholding
15th Dec 20155:31 pmRNSHolding(s) in Company
14th Dec 201510:38 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.